Receive the latest alerts via email

New stock valuation – Biogen Inc(BIIB)

Biogen Inc (NASDAQ:BIIB) over-valued by 10%

Website https://www.biogen.com/
Sector Healthcare
Industry Drug Manufacturers General
Fiscal Year End Dec 31, 2021
Market Cap $42,418,872,320
Beta 0.436845
Average Volume $1,088,167
Last Dividend 0%
Price on Feb 3, 2022 $226.81
Autochartist™ Valuation $203.47
Conclusion
10%
over-valued
Download Report
Total
0
Shares
Previous Post

New stock valuation – Pultegroup Inc(PHM)

Next Post

US30 – breach of a trending support line that has been tested at least twice before.

ARTÍCULOS RELACIONADOS